Åse Bratland (born 1977) PhD, is a specialist in oncology and a senior consultant. She is chief consultant for skin cancer at the Norwegian Radium Hospital.
The author has completed the ICMJE form and declares no conflicts of interest.
Department of Oncology
Oslo University Hospital, Norwegian Radium Hospital
Gorlin RJ, Goltz RW. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. N Engl J Med 1960; 262: 908 – 12. [PubMed] [CrossRef]
3.
Gilhuus-Moe O, Haugen LK, Dee PM. The syndrome of multiple cysts of the jaws, basal cell carcinomata and skeletal anomalies. Br J Oral Surg 1968; 5: 211 – 22. [PubMed] [CrossRef]
4.
Evans DG, Howard E, Giblin C et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 2010; 152A: 327 – 32. [PubMed] [CrossRef]
5.
Evans DG, Ladusans EJ, Rimmer S et al. Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet 1993; 30: 460 – 4. [PubMed] [CrossRef]
6.
Evans D, Farndon P. Nevoid basal cell carcinoma syndrome. I: Pagon RA, Adam MP, Ardinger HH, red. GeneReviews®. Oppdatert 7.3.2013. Seattle, WA: University of Washington, Seattle, 2002.
7.
Kimonis VE, Goldstein AM, Pastakia B et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 1997; 69: 299 – 308. [PubMed]
8.
Lo Muzio L. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis 2008; 3: 32. [PubMed] [CrossRef]
9.
Wicking C, Shanley S, Smyth I et al. Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. Am J Hum Genet 1997; 60: 21 – 6. [PubMed]
10.
Wilding A, Ingham SL, Lalloo F et al. Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet 2012; 49: 264 – 9. [PubMed] [CrossRef]
11.
Helsedirektoratet. En sjelden guide: Et hefte for deg som har eller møter mennesker med sjeldne tilstander. IS-1021. Oslo: Helsedirektoratet, 2012.
12.
Helsedirektoratet. Født med en sjelden diagnose. Med sterk vilje og systematisk hjelp kan hverdagen bli bra! IS-1892. Oslo: Helsedirektoratet, 2011.
13.
Bree AF, Shah MR. Consensus statement from the first international colloquium on basal cell nevus syndrome (BCNS). Am J Med Genet A 2011; 155A: 2091 – 7. [PubMed] [CrossRef]
14.
Cowan R, Hoban P, Kelsey A et al. The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma. Br J Cancer 1997; 76: 141 – 5. [PubMed] [CrossRef]
15.
Mancuso M, Pazzaglia S, Tanori M et al. Basal cell carcinoma and its development: insights from radiation-induced tumors in Ptch1-deficient mice. Cancer Res 2004; 64: 934 – 41. [PubMed] [CrossRef]
16.
Choudry Q, Patel HC, Gurusinghe NT et al. Radiation-induced brain tumours in nevoid basal cell carcinoma syndrome: implications for treatment and surveillance. Childs Nerv Syst 2007; 23: 133 – 6. [PubMed] [CrossRef]
17.
Sartip K, Kaplan A, Obeid G et al. Neuroimaging of nevoid basal cell carcinoma syndrome (NBCCS) in children. Pediatr Radiol 2013; 43: 620 – 7. [PubMed] [CrossRef]
18.
Tang JY, Wu A, Linos E et al. High prevalence of vitamin D deficiency in patients with basal cell nevus syndrome. Arch Dermatol 2010; 146: 1105 – 10. [PubMed] [CrossRef]
19.
Shah M, Mavers M, Bree A et al. Quality of life and depression assessment in nevoid basal cell carcinoma syndrome. Int J Dermatol 2011; 50: 268 – 76. [PubMed] [CrossRef]
20.
Sandhiya S, Melvin G, Kumar SS et al. The dawn of hedgehog inhibitors: Vismodegib. J Pharmacol Pharmacother 2013; 4: 4 – 7. [PubMed] [CrossRef]
21.
Sekulic A, Migden MR, Oro AE et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 2012; 366: 2171 – 9. [PubMed] [CrossRef]
22.
Tang JY, Mackay-Wiggan JM, Aszterbaum M et al. Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med 2012; 366: 2180 – 8. [PubMed] [CrossRef]
This article was published more than 12 months ago and we have therefore closed it for new comments.
Published: 17 June 2014
Tidsskr Nor Legeforen 17 June 2014
doi:
10.4045/tidsskr.13.0894
Received 2 August 2013, first revision submitted 10 December 2013, accepted 21 March 2014. Editor: Siri Lunde Strømme.
If you do not see the PDF file or want to save the file, you can right-click on the PDF icon. Select «Save target / file as ...» and then retrieve the PDF file in, for example, Acrobat Reader.